Fibroblast growth factor receptor inhibitor-induced hyperphosphatemia: Lessons for the nephrologist
Collaboration between nephrologists and oncologists is crucial for optimizing treatment benefits and managing side effects. Further research is warranted to refine management strategies and to understand the clinical implications of hyperphosphatemia.
Authors
- Kenar D. Jhaveri (ORCID: https://orcid.org/0000-0003-1578-0524)
- Rose Mary Attieh (ORCID: https://orcid.org/0009-0000-2603-360X)
- Venkatesh Upadrista (ORCID: https://orcid.org/0000-0002-8601-5830)
- Anna T. Levy
Publication Details
- Journal
- Clinical Nephrology
- Published
- 2024-11-19
- DOI
- https://doi.org/10.5414/cn111488
- Citations
- 1
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.34